Resumen

GAMBOA, Óscar et al. Direct costs of breast cancer care in Colombia. rev.colomb.cancerol. [online]. 2016, vol.20, n.2, pp.52-60. ISSN 0123-9015.  https://doi.org/10.1016/j.rccan.2016.02.003.

Objective: To estimate the cost of managing each of the stages of breast cancer in Colombia. Methods: The estimation of costs was performed using case study methodology, divided into three stages: the identification of the use of resources associated with the different stages of the disease, the quantification of the resource use, and the evaluation of this use. The quantity, frequency of use, and the percentage of compliance with procedures and medications were obtained by expert opinion in the cancer centres in five regions of the country (Bogotá, Barranquilla-Cartagena, Cali, Medellin and Bucaramanga). The drug costs were calculated using prices reported in the Price of Medications Information System (SISMED) 2010, and Resolution 4316 of 2011. The procedure costs were obtained from the ISS 2001 manuals + 30%, SOAT and information from the UPC sufficiency study. Results: The most expensive stages of breast cancer were metastatic cancer at a cost of COP $144,400,865 and regional cancer with COP $65,603,537 (D 56 million). A significant contribution by chemotherapy was observed in the total cost for the different stages and systemic and local recurrence. Conclusion: The difference in costs between the stages of breast cancer is highly influenced by the value of the costs associated with chemotherapy treatment.

Palabras clave : Breast Neoplasms; Costs and Cost Analysis; Cost of Illness; Colombia.

        · resumen en Español     · texto en Español     · Español ( pdf )